The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study.
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; Ipsen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; MSD Oncology; Roche
Research Funding - Bayer; Eisai; Ipsen; MSD; Sirtex Medical
 
Min-Hee Ryu
Honoraria - AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Imam Waked
Speakers' Bureau - Bayer; Eva Pharma; Gilead Sciences; Roche
Research Funding - Abbvie; Arena Pharma; AstraZeneca
Travel, Accommodations, Expenses - Eva Pharma
 
Yu Yun Shao
Honoraria - AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Eisai; Ipsen; Lilly; Merck; Ono Pharmaceutical; Roche
Speakers' Bureau - AstraZeneca; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Eisai; Lilly; Merck; Merck Serono; Ono Pharmaceutical; Roche
Research Funding - AstraZeneca
 
Wai Meng David Tai
Honoraria - Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Roche
Research Funding - Bristol-Myers Squibb; Novartis; Sirtex Medical
 
Valeriy Breder
No Relationships to Disclose
 
Ashwaq Alolayan
No Relationships to Disclose
 
Sandip Ganguly
Research Funding - AstraZeneca/MedImmune (Inst); Novartis (Inst)